International Journal of Endocrinology (Jan 2025)
Role of Serum Lithium Concentrations in Predicting Hyperparathyroidism and Hypercalcemia
Abstract
Conclusions: This study confirmed that the high incidence of hyperparathyroidism and hypercalcemia in patients treated with Li. Clinicians should be aware that Li treatment may induce hyperparathyroidism, and a serum Li concentration exceeding 0.52 mEq/L may pose an increased risk. Monitoring serum calcium and Li concentrations is recommended in patients undergoing Li treatment.